LU74695A1 - - Google Patents

Info

Publication number
LU74695A1
LU74695A1 LU74695A LU74695A LU74695A1 LU 74695 A1 LU74695 A1 LU 74695A1 LU 74695 A LU74695 A LU 74695A LU 74695 A LU74695 A LU 74695A LU 74695 A1 LU74695 A1 LU 74695A1
Authority
LU
Luxembourg
Application number
LU74695A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU74695A1 publication Critical patent/LU74695A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU74695A 1975-04-04 1976-04-02 LU74695A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2515001A DE2515001C2 (de) 1975-04-04 1975-04-04 Prostaglandin enthaltende gefriergetrocknete Pulver

Publications (1)

Publication Number Publication Date
LU74695A1 true LU74695A1 (cg-RX-API-DMAC7.html) 1976-11-11

Family

ID=5943206

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74695A LU74695A1 (cg-RX-API-DMAC7.html) 1975-04-04 1976-04-02

Country Status (13)

Country Link
US (1) US4058623A (cg-RX-API-DMAC7.html)
JP (1) JPS5940147B2 (cg-RX-API-DMAC7.html)
BE (1) BE840357A (cg-RX-API-DMAC7.html)
CH (1) CH637375A5 (cg-RX-API-DMAC7.html)
DE (1) DE2515001C2 (cg-RX-API-DMAC7.html)
DK (1) DK146435C (cg-RX-API-DMAC7.html)
FI (1) FI59022C (cg-RX-API-DMAC7.html)
FR (1) FR2305972A1 (cg-RX-API-DMAC7.html)
GB (1) GB1540483A (cg-RX-API-DMAC7.html)
IE (1) IE42671B1 (cg-RX-API-DMAC7.html)
LU (1) LU74695A1 (cg-RX-API-DMAC7.html)
NL (1) NL183439C (cg-RX-API-DMAC7.html)
SE (1) SE427006B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA787353B (en) * 1978-05-17 1980-08-27 Wellcome Found Pharmaceutical formulations
US4301146A (en) * 1980-07-29 1981-11-17 G. D. Searle & Co. Stabilization of 16-oxygenated prostanoic acid derivatives
DE3162914D1 (en) * 1981-01-10 1984-05-10 Chinoin Gyogyszer Es Vegyeszet Stabilized prostaglandin tablets for topical use with regulated dissolving speed and process for preparing them
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
US4835320A (en) * 1986-06-03 1989-05-30 Societe Francaise Hoechst Process for the preparation of glyoxal monoactals
US4857711A (en) * 1988-08-16 1989-08-15 Illinois Tool Works Inc. Positive temperature coefficient heater
JPH02149353U (cg-RX-API-DMAC7.html) * 1989-05-22 1990-12-19
JPH03107251U (cg-RX-API-DMAC7.html) * 1989-06-30 1991-11-05
DE4125255A1 (de) * 1991-07-31 1993-02-04 Knoll Ag Prostaglandin e (pfeil abwaerts)1(pfeil abwaerts)-formulierung
CA2222811C (en) * 1995-06-01 2008-09-30 G.D. Searle & Co. Stabilized solid dispersions of misoprostol
AU4218400A (en) * 1999-04-05 2000-10-23 Emisphere Technologies, Inc. Lyophilized solid dosage forms and methods of making
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069322A (en) * 1958-05-28 1962-12-18 Bergstrom Sune Pge and pgf
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
FR2157899A1 (en) * 1971-10-22 1973-06-08 Upjohn Co 16-mono and di-lower alkyl prostaglandin compsns - - for treatment of peptic ulcers
US3904679A (en) * 1972-05-23 1975-09-09 Upjohn Co 15-Methyl and 15-ethyl prostaglandin F{HD 2{331 {0 {B analogs
US3826823A (en) * 1972-09-25 1974-07-30 Syntex Inc Stabilized prostaglandin preparations
US3954787A (en) * 1974-06-18 1976-05-04 Pfizer Inc. Stabilized E-series prostaglandins

Also Published As

Publication number Publication date
IE42671B1 (en) 1980-09-24
NL7603043A (nl) 1976-10-06
SE427006B (sv) 1983-02-28
CH637375A5 (de) 1983-07-29
NL183439C (nl) 1988-11-01
SE7603741L (sv) 1976-10-05
FI760800A7 (cg-RX-API-DMAC7.html) 1976-10-05
GB1540483A (en) 1979-02-14
FR2305972B1 (cg-RX-API-DMAC7.html) 1979-09-21
DE2515001A1 (de) 1976-10-14
JPS5940147B2 (ja) 1984-09-28
DE2515001C2 (de) 1986-10-02
JPS51127048A (en) 1976-11-05
BE840357A (fr) 1976-10-04
FI59022B (fi) 1981-02-27
DK131976A (da) 1976-10-05
IE42671L (en) 1976-10-04
FI59022C (fi) 1981-06-10
US4058623A (en) 1977-11-15
DK146435C (da) 1984-03-26
FR2305972A1 (fr) 1976-10-29
NL183439B (nl) 1988-06-01
DK146435B (da) 1983-10-10

Similar Documents

Publication Publication Date Title
JPS5278321U (cg-RX-API-DMAC7.html)
CH598649A5 (cg-RX-API-DMAC7.html)
CH599008A5 (cg-RX-API-DMAC7.html)
BG22237A1 (cg-RX-API-DMAC7.html)
BG22326A1 (cg-RX-API-DMAC7.html)
BG22556A1 (cg-RX-API-DMAC7.html)
BG22721A1 (cg-RX-API-DMAC7.html)
BG22919A1 (cg-RX-API-DMAC7.html)
BG23472A1 (cg-RX-API-DMAC7.html)
CH1132075A4 (cg-RX-API-DMAC7.html)
CH1667475A4 (cg-RX-API-DMAC7.html)
CH325575A4 (cg-RX-API-DMAC7.html)
CH574658A5 (cg-RX-API-DMAC7.html)
CH578420A5 (cg-RX-API-DMAC7.html)
CH579725A5 (cg-RX-API-DMAC7.html)
CH579782A5 (cg-RX-API-DMAC7.html)
CH580802A5 (cg-RX-API-DMAC7.html)
CH583884A5 (cg-RX-API-DMAC7.html)
CH584087A5 (cg-RX-API-DMAC7.html)
LU74695A1 (cg-RX-API-DMAC7.html)
CH584811A5 (cg-RX-API-DMAC7.html)
CH587973A5 (cg-RX-API-DMAC7.html)
CH589559A5 (cg-RX-API-DMAC7.html)
CH591747A5 (cg-RX-API-DMAC7.html)
CH592911B5 (cg-RX-API-DMAC7.html)